Metis TechBio 与礼来公司就药物递送技术达成最高达 11 亿美元的协议

路透中文
Oct 19
Metis TechBio 与<a href="https://laohu8.com/S/LLY">礼来</a>公司就药物递送技术达成最高达 11 亿美元的协议

路透10月19日 - 在香港上市的Metis TechBio(7666.HK)周一表示,已与礼来公司(LLY.N)签署了一项合作协议,双方将共同研发组织特异性药物递送技术,该协议价值最高可达11亿美元。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10